Biocept DSO Ratio 2011-2026 | BIOC

Annual DSO Ratio Biocept

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
112	83.2	188	233	177	85.9	14.6	20.5	29	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
233	14.6	105

Quarterly DSO Ratio Biocept

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
148	221	-	271	264	68.9	-	74.6	113	80.4	-	196	1.41 K	557	180	210	270	227	167	189	175	156	109	98	85.2	35.9	9.11	11.2	17.8	33.6	14.3	18.9	40.6	13.6	12.8	94.2	50.3	31.9	44.6	26.3	17.4	11.9	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.41 K	9.11	148

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
Agilent Technologies A	63.8	$ 115.07	0.1 %	$ 35 B	USA
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	94.7	$ 8.93	76.13 %	$ 11.9 M	USA
Castle Biosciences CSTL	50.2	$ 19.61	-2.66 %	$ 568 M	USA
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	72.7	-	-61.36 %	$ 2.46 M	USA
Fulgent Genetics FLGT	87	$ 17.44	1.93 %	$ 537 M	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
CareDx, Inc CDNA	51.5	$ 21.74	0.51 %	$ 1.16 B	USA
Guardant Health GH	46.1	$ 119.74	0.66 %	$ 15 B	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Interpace Biosciences IDXG	66.9	$ 1.8	-1.1 %	$ 7.96 M	USA
ICON Public Limited Company ICLR	68.5	$ 115.71	-0.92 %	$ 9.54 B	Irlanda
Illumina ILMN	61.3	$ 145.77	0.94 %	$ 23.2 B	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
Lantheus Holdings LNTH	80.5	$ 100.62	-2.31 %	$ 6.79 B	USA
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
Charles River Laboratories International CRL	65	$ 155.98	-2.69 %	$ 7.73 B	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Medpace Holdings MEDP	50.4	$ 424.32	-1.96 %	$ 12.2 B	USA
Mettler-Toledo International MTD	66.4	$ 1 098.91	-0.38 %	$ 22.6 B	Schweiz
NeoGenomics NEO	77.7	$ 9.24	0.11 %	$ 1.18 B	USA
National Research Corporation NRC	29.4	$ 18.86	-1.15 %	$ 422 M	USA
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Natera NTRA	81.5	$ 200.36	-1.39 %	$ 19.7 B	USA
Myriad Genetics MYGN	52.3	$ 3.81	-0.39 %	$ 353 M	USA
Personalis PSNL	63.8	$ 9.1	7.38 %	$ 812 M	USA
Senseonics Holdings SENS	1.04	$ 6.53	2.92 %	$ 272 M	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	27	-	-	$ 2.69 B	USA
Biomerica BMRA	57.7	$ 2.39	-4.02 %	$ 5.49 M	USA
Laboratory Corporation of America Holdings LH	52.9	$ 259.7	-0.09 %	$ 21.6 B	USA
Twist Bioscience Corporation TWST	44.5	$ 64.5	6.48 %	$ 3.86 B	USA
Thermo Fisher Scientific TMO	70	$ 448.21	-0.02 %	$ 169 B	USA
Trinity Biotech plc TRIB	87.2	$ 0.64	6.31 %	$ 230 M	Irlanda
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	66.6	$ 9.11	2.36 %	$ 1.98 B	USA
Waters Corporation WAT	306	$ 341.19	-0.34 %	$ 20.3 B	USA
Quest Diagnostics Incorporated DGX	44.9	$ 193.27	-0.99 %	$ 21.5 B	USA